THC Therapeutics, Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Scott A. Cox
- Full Time Employees
- 1
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 11700 W Charleston Boulevard Las Vegas NV United States of America 89135
- IPO Date
- Jan 23, 2017
- CIK
- 0001404935
- Website
- thct.io
- Similar Companies
- Business
- THC Therapeutics, Inc. (THCT) operates as a holding company focused on acquiring and developing assets in the legal cannabis industry, including cultivation, manufacturing, distribution, and ancillary technologies; it develops the dHydronator, a patented sanitizing herb and cannabis dryer that reduces drying time to 12-14 hours while eliminating bacteria via ultraviolet light, and pursues cannabinoid and terpene formulations for tailored effects through THCT Formulations and THCT Technologies. The company maintains operations in key U.S. markets such as California and Oregon, targeting vertically integrated seed-to-sale capabilities with brands spanning genetics, extraction, nutrients via subsidiaries like NPK Industries, and consumer products including pre-rolls and craft cannabis offerings. Founded in 2007 and headquartered in Jacksboro, Texas, with prior addresses in Las Vegas, Nevada, THC Therapeutics pursues a roll-up strategy, highlighted by its June 2025 acquisition of The Headquarters Group, Inc. for $11 million in preferred stock to gain a portfolio of synergistic cannabis companies generating $4.8 million in revenue and over 60 years of combined expertise, followed by the July 2025 acquisition of SugarTop Buddery, a ten-year Oregon legacy brand in pre-rolls, contract manufacturing, and statewide distribution, to expand its bi-coastal national footprint.
THC Therapeutics, Inc. Announces Filing of 10-K and Provides Corporate Update
THC Therapeutics, Inc. Announces Acquisition of SugarTop Buddery
THC Therapeutics, Inc. Announces Acquisition of Oregon and California Consortium of Cannabis Companies
THC Therapeutics, Inc. Announces Acquisition of Oregon and California Consortium of Cannabis Companies
THC Therapeutics Secures $50M From Shefford Capital Partners To Support Cannabis Acquisitions
THC Therapeutics Has Completed the dHydronator(R) Consumer Model Design
THC Therapeutics Has Completed the dHydronator® Consumer Model Design with photos
THC Therapeutics Engage Milestone Management Services for Investor Relations
THC Therapeutics Has Begun the Process of Acquiring A Significant Amount of Physical Silver Bullion
THC Therapeutics Has Joined the Las Vegas Medical Marijuana Association.
Future Business Plans of THC Therapeutics on Increasing Shareholder Value Via a Reg A+
THC Therapeutics, Inc. Independently Tested, Patented Sanitizing Cannabis Dryer More Relevant Than Ever